EPS produced by L
(a4-2) neohesperidin dihydrochalcone, naringin dihydrochalcone, stevioside, steviolbioside, rebaudioside, in particular rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, rebaudioside G, rebaudioside H, dulcoside and rubusoside, rubusoside A, rubusoside B, rubusoside G, rubusoside H, rubusoside I, rubusoside J, cloudbursin 1, cloudbursin 2, phlomisoside 1, phlomisoside 2, phlomisoside 3 and phlomisoside 4, phlomisoside A, phyllusoside B, phyllusoside C, myristyl triterpene D, cyclocarioside A and cyclocarioside I, aureoside, polypodophylloside A, myristyl triterpene C, myristyl triterpene D, cyclocarioside A, and cyclocarioside I, phlomisoside A, polypodophyllostilbene A, myristyl 2, myristyl malastyle A, myristyl malastyle 2, stellaria malastyle 4, and D, Drynaria A, dihydroquercetin-3-acetate, artemisia perillea, teleomoside A15, peroxide IV, baicalin, cyclocarya paliurus, sapindoside, trans-anethole, trans-cinnamaldehyde, bryosides, bryonosides, bryonodulides, fleshy hemsleyagarousides, gynura segetum chenifolia hemsl glycosides, gynosaponin, trilobatin, phlorizin, dihydroflavanol, hematoxylin, cyanine, chlorogenic acid, synthetic saponin, verbascoside, digitoside, mogroside V, camphorsulfonic acid, monatin, phyllodulcin, glycyrrhetinic acid and derivatives thereof and mixtures thereof, especially glycosides thereof such as glycyrrhizin, especially sodium, potassium, calcium or ammonium salts
PLoS One 11(5):e0155643
Rheumatology 48 , 13091313 (2009)
